“There is a surprising lack of data comparing buprenorphine—the most common treatment for opioid use disorder—with no treatment. We found that the benefits of treatment were profound, substantially reducing risk of preterm birth and severe maternal morbidity.” - @stephenwpatrick.bsky.social
Posts by Sunaya Krishnapura, MD
Grateful to have been a part of this research team and for the mentorship of @stephenwpatrick.bsky.social!
At least 50% of pregnant women with opioid use disorder nationwide do not receive treatment
Our study in JAMA Health Forum found that buprenorphine treatment was associated with significant improvements in outcomes for mothers and infants
Full paper: ja.ma/3EyF00J
www.healio.com/news/pediatr...
Figure. Adverse Pregnancy Outcomes Among Pregnant People With Opioid Use Disorder in Tennessee, 2010-2021
From JAMA Health Forum: Buprenorphine treatment during pregnancy for opioid use disorder was associated with significantly improved maternal and infant outcomes compared to no treatment. #PAS2025
https://ja.ma/3EyF00J
Pregnant women with opioid use disorder face huge barriers to treatment.
Our new study: Buprenorphine = fewer preterm births, fewer severe maternal complications.
Treatment saves lives & we found ~5 percentage point reduction in preterm birth.
Study ➔ sph.emory.edu/news/news-re...